Percutaneous patent ductus arteriosus closure: Twelve years of experience

Sarmento, João Antunes; Correia-Costa, Ana; Gonçalves, Edison; Baptista, Maria João; Silva, João Carlos; Moreira, Jorge

doi:10.1016/j.repce.2020.09.009

Cited by 3 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only one thromboembolic event occurred during the complete follow-up period 21 . On the other hand, studies conducted in Portugal have proven similar success rates as the previously mentioned with a 1.8% complication rate post-procedure reported 22 .…”

Section: Discussionsupporting

confidence: 75%

Experiencia del cierre percutáneo de conducto arterioso persistente de pequeño a grande con el dispositivo Nit-Occlud<sup>®</sup> en un hospital de referencia terciaria en Colombia

Galvis-Luna,

Guzmán-Serrano,

Olave-Rueda

et al. 2024

ACM

View full text Add to dashboard Cite

Background:The decision to close patent ductus arteriosus should always be individualized and taken together with the child's family once the risks and benefits of both choices have been exposed. Objective: This study aims to report the experience and outcomes in patients undergoing endovascular closure of small to medium-size PDA with a Nit-Occlud ® device in a tertiary referral hospital in Colombia. Methods: Longitudinal descriptive study, which included all patients under 18 years of age who underwent percutaneous ductal closure with Nit-Occlud ® device between January 1, 2011, and February 1, 2023. Patients with associated complex congenital heart disease requiring surgical management, pregnant patients, and patients with incomplete data regarding studied variables were excluded from the study. Results: Eighty-seven patients were documented, with a mean age, weight, and height at closure of 51 months, 14 kg, and 95.83 cm, respectively. About 70% of the patients (n = 61) were female, 76% were under 6-years-old and only one patient was over 15. The average size of the ductus at the pulmonary end was 2 mm. Four of the total number of patients did not achieve PDA closure during the procedure. Of the remaining 83, complete immediate closure was achieved in 81 patients. A device exchange for a larger device was required during the same procedure in one of the cases. Two patients presented residual shunt of 0.5 mm during follow-up, and one required a new procedure for device closure 10 months later. Only one device presented repeatedly embolization to the aorta, requiring surgical removal. As a technical difficulty, one device presented repeated passage into the aorta, so it was decided to remove it before releasing it to avoid complications, and given the complex anatomy of the ductus, surgical closure was indicated. Among the complications, one patient presented a hematoma of the subcutaneous tissue in the right thigh, which improved with medical management, and no deaths related to the procedure were registered. Conclusions: Using the Nit-Occlud ® device to close small to moderate-sized ductus remains a safe and effective strategy with successful closure rates at 1-year follow-up irrespective of age, weight, height, or whether it involves a small or medium-sized duct. Despite our limitations, results concerning adverse effects are comparable to those observed in multicentric studies conducted in other regions.

show abstract

Section: Discussionsupporting

confidence: 75%

Experiencia del cierre percutáneo de conducto arterioso persistente de pequeño a grande con el dispositivo Nit-Occlud<sup>®</sup> en un hospital de referencia terciaria en Colombia

Galvis-Luna,

Guzmán-Serrano,

Olave-Rueda

et al. 2024

ACM

View full text Add to dashboard Cite

show abstract

“…It is known that certain factors, such as a history of prematurity 1 , genetic syndromes 4 , or the altitude above sea level from which the patient originates 5 , predispose to the PDA. Depending on the size and age of the patient, there may be symptoms of congestive heart failure 6 , risk of pulmonary hypertension, risk of endarteritis, and even reports of aneurysm of the ductus arteriosus 7 .…”

Section: Introductionmentioning

confidence: 99%

Uso de la ecocardiografía en el cierre percutáneo de ductus arterioso persistente en el Instituto Nacional de Salud del Niño, San Borja,Lima – Perú

Catalán,

Condori,

Medina

et al. 2024

Arch Peru Cardiol Cir Cardiovasc

View full text Add to dashboard Cite

Objetive. Percutaneous occlusion of patent ductus arteriosus (PDA) has classically been performed entirely by fluoroscopy, however in recent years, transthoracic echocardiography (TE) has been used as an aid to fluoroscopy or entirely by echocardiography, which avoids access of femoral artery, use of contrast and decrease in time and dose of radiation exposure. The objective of this study was to evaluate the success rate with the use of TE in percutaneous PDA closure. Material and method. Descriptive, comparative, retrospective study between patients in whom PDA closure was performed with fluoroscopy plus angiography (group 1) and fluoroscopy plus ET (group 2), between January 2018 and December 2022. The data were obtained from the clinical history electronic and procedure report. Results. One hundred eight patients were analyzed, fluoroscopy group (n: 57) and TE (n: 51). The success rate in PDA occlusion using TE was 100% and 98% for the fluoroscopy group, with no statistically significant difference The average age of group 2 was 2.9 years, while the average age of group 1 was 5 years (p=0.001), the average fluoroscopy time in group 1 was 16.9 min and 4.71 min in group 2 (p < 0.001); the fluoroscopy dose in group 1 was 68.98 mGy and 5.17 mGy in group 2 (p<0.001). Krichenko, but without significant difference in both groups. Conclusions. The success rate of percutaneous PDA closure using echocardiography and fluoroscopy is appropiate, with a success rate similar to the classic technique. In addition, it makes it possible to reduce the dose and time of fluoroscopy, avoid the use of contrast, and access the femoral artery.

show abstract

Safety and Efficacy of the Nit-Occlud® Coil for Percutaneous Closure of Various Sizes of PDA

Jung

Seol

Choi

et al. 2022

JCM

View full text Add to dashboard Cite

Most interventionalists use the Amplatzer Duct Occluder (ADO) or the Nit-Occlud® Coils (NOC) to close patent ductus arteriosus (PDA). Data regarding the success and effect of NOCs in the occlusion of large PDAs are insufficient. We aimed to investigate whether the PDA occlusion of large PDAs using NOC is safe and efficient for all ages. This was a retrospective study involving 361 pediatric and adult patients who underwent the transcatheter closure of PDA using NOC over the past 21 years for all PDA sizes and ages. The sizes of PDA were classified as small, moderate, and large. A comparison of the aortic pressure before and after PDA occlusion using NOC showed significant differences in terms of systolic and pulse pressures for all age groups (p < 0.05). The rate of the residual shunts of NOC was 2%, while the rate of complete occlusions of NOC was 98% at 12 months after occlusion regardless of the shape of PDA. The complication rate with PDA occlusion using NOC was 5%. PDA occlusion using NOC is as effective and safe as ADO for the occlusion of PDA of all sizes. Therefore, PDA occlusion using NOC can be a safe and feasible procedure to close various sizes and types of PDA without complications.

show abstract

Percutaneous patent ductus arteriosus closure: Twelve years of experience

Cited by 3 publications

References 21 publications

Experiencia del cierre percutáneo de conducto arterioso persistente de pequeño a grande con el dispositivo Nit-Occlud<sup>®</sup> en un hospital de referencia terciaria en Colombia

Experiencia del cierre percutáneo de conducto arterioso persistente de pequeño a grande con el dispositivo Nit-Occlud<sup>®</sup> en un hospital de referencia terciaria en Colombia

Uso de la ecocardiografía en el cierre percutáneo de ductus arterioso persistente en el Instituto Nacional de Salud del Niño, San Borja,Lima – Perú

Safety and Efficacy of the Nit-Occlud® Coil for Percutaneous Closure of Various Sizes of PDA

Contact Info

Product

Resources

About